JPSIM Journal of Pakistan Society of Internal Medicine J Pak Soc Intern Med 2709-8729 2710-0804 Pakistan Society of Internal Medicine 10.70302/jpsim.v6i2.2523 jpsim.v6i2.2523 Original Research Frequency of Visual Impairment in Idiopathic Intracranial Hypertension Murtaza Ghulam Bano Safia safiabano207@gmail.com * Husnain Muhammad Hasnat Muhammad Javed Athar GMC/DHQ Teaching Hospital, Gujranwala Department of Neurology, Mayo Hospital, Lahore Professor of Neurology, National Hospital and Medical Center, Lahore *Correspondence: Safia Bano (safiabano207@gmail.com) 05 06 2025 2025 6 2 119 122 09 05 2024 15 01 2025 25 04 2025 Copyright © 2025 The Author(s) 2025 The Author(s) https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Objective

To determine the frequency of visual impairment in Idiopathic Intracranial Hypertension (IIH)

 Methodology

A descriptive Cross-Sectional study was undertaken at the Department of Neurology, Mayo Hospital, Lahore, Pakistan from June 2023 to November 2023. After attaining IRB approval and informed consent from the patients, eligibility criteria were met and 129 patients were included in the study. A pre-designed form was used to document their clinical history and demographic information. Visual impairment was defined as the presence of any of the following: (a) blurring of vision, (b) diplopia, (c) reduced vision, or (d) compromised color vision.

 Results

The mean age of the patients was 32.98 ± 9.62 years. Out of the total, 32 patients (24.81%) were male, while 97 (75.19%) were female. There was decreased vision in 84 (65.1%) patients, diplopia in 64 (49.6%) patients, impaired color vision in 98 (76%) patients, and blurred vision was noted in 77(59.7%) patients. The data analysis found no evidence linking obesity to a higher occurrence of visual impairment. Furthermore, no correlation between gender and the frequency of visual impairment was observed.

 Conclusion

Impaired color vision was the most prevalent visual impairment, occurring in 76% of the individuals, followed by decreased vision, blurring of vision and diplopia in order of occurrence in patients with IIH.

 Keywords Visual Impairment. Idiopathic Intracranial Hypertension (IIH) References Takkar A, Goyal MK, Bansal R, Lal V. Clinical and neuro-ophthalmologic predictors of visual outcome in idiopathic intracranial hypertension. Neuro-Ophthalmol. 2018;42(4):201-8. Huang LC, Winter TW, Herro AM, Rosa PR, Schiffman JC, Pasol J, et al. Ventriculoperitoneal shunt as a treatment of visual loss in idiopathic intracranial hypertension. J Neuro-Ophthalmol. 2014;34(3):223-8. Saindane AM, Bruce BB, Riggeal BD, Newman NJ, Biousse V. Association of MRI findings and visual outcome in idiopathic intracranial hypertension. Am J Roentgenol. 2013;201(2):412-8. Szewka AJ, Bruce BB, Newman NJ, Biousse V. Idiopathic intracranial hypertension: relation between obesity and visual outcomes. J Neuro-Ophthalmol. 2013;33(1):4-8. Baheti N, Nair M, Thomas S. Long-term visual outcome in idiopathic intracranial hypertension. Ann Indian Acad Neurol. 2011;14(1):19. Afonso CL, Talans A, Monteiro MLR. Factors affecting visual loss and visual recovery in patients with pseudotumor cerebri syndrome. Arqu Brasil oftalmol. 2015;78(3):175-9. Kilgore KP, Lee MS, Leavitt JA, Mokri B, Hodge DO, Frank RD, Chen JJ. Re-evaluating the incidence of idiopathic intracranial hypertension in an era of increasing obesity. Ophthalmol. 2017;124(5):697-700.. Rowe FJ, Sarkies NJ. Assessment of visual function in idiopathic intracranial hypertension: a prospective study. Eye. 1998;12(1):111-8. Corbett JJ, Savino PJ, Thompson HS, Kansu T, Schatz NJ, Orr LS, et al. Visual loss in pseudotumor cerebri: follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol. 1982;39(8):461-74. Obuchowska I, Mariak Z. The importance of visual field testing in patients with papilledema and idiopathic intracranial hypertension. Klinika Oczna. 2017;119(1):13-7.